Strona główna・Stock List・Progyny Inc

Progyny Inc

Open

SectorHealthcare

27.8 -0.82

Buy Sell

Overview

Share price change

24h

Current

Min

27.89

Max

28.85

Key metrics
By Trading Economics
Income	12M 24M
Sales	10M 329M
P/E Sector Avg	40.429 68.51
EPS	0.5
Profit margin	7.376
Employees	835
EBITDA	19M 38M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+18.15% upside

Dividends
By Acuity
Next Earnings	5 lis 2026

Market Stats
By TradingEconomics
Market Cap	890M 2.4B
Previous open	28.62
Previous close	27.8

News Sentiment

By Acuity

50%

116 / 340 Ranking in Healthcare

Progyny Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

7 sie 2026, 20:02 UTC

News

Progyny Inc's shares are lower after a cautious Q3 sales outlook, despite reporting revenue of $350.5 million that exceeded analyst expectations.

6 sie 2026, 23:02 UTC

News

Progyny Inc shares are lower in after-market trading following a revenue guidance cut to $1.36 billion to $1.39 billion, below previous estimates.

31 lip 2026, 19:46 UTC

Progyny Inc shares are lower today amid broader market pressures and rising bond yields. No specific company news was identified to explain the decline.

30 lip 2026, 21:02 UTC

Progyny Inc shares are lower in after-market hours, with no specific news identified for the decline. The stock is below its 20-day moving average.

29 lip 2026, 18:55 UTC

Progyny Inc shares are higher today, reflecting notable strength in trading. The stock remains above its 20-day moving average.

28 lip 2026, 17:41 UTC

News

Social Media

Progyny Inc shares are lower following a downgrade by Barclays, which noted slowing website traffic growth at fertility clinics. Price target raised to $34 from $27.

24 lip 2026, 15:06 UTC

News

BTIG maintained its Buy rating on Progyny and raised the price target to $40. Shares are trading higher, remaining above the 20-day moving average.

22 lip 2026, 20:01 UTC

News

Progyny Inc shares are lower despite the acceptance of benefits at Pinnacle Fertility New York, enhancing access to reproductive care for members.

20 lip 2026, 17:16 UTC

Progyny Inc shares are higher today, maintaining a position near their one-month trading range. No specific news was identified to explain the movement.

Peer Comparison

Price change

Progyny Inc Forecast

Price Target

By TipRanks

18.15% upside

12 Months Forecast

Average 33.2 USD 18.15%

High 40 USD

Low 27 USD

Based on 11 Wall Street analysts offering 12 month price targets forProgyny Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

11 ratings

Buy

Hold

Sell

Based on 11 analysts giving stock ratings to Progyny Inc - Dist in the past 3 months.

Sentiment

By Acuity

116 / 340 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Progyny Inc

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.